Loading…
Encompass Health Corporation is projected to rise to $131.31 by 2027, a +18% move from its current price of $110.89. EHC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $109.39 | $110.91 | $112.46 | +0.02% |
| Aug 2 | $108.79 | $110.94 | $113.14 | +0.04% |
| Aug 3 | $108.33 | $110.96 | $113.66 | +0.07% |
| Aug 4 | $107.95 | $110.99 | $114.11 | +0.09% |
| Aug 5 | $107.62 | $111.01 | $114.51 | +0.11% |
| Aug 6 | $107.33 | $111.04 | $114.88 | +0.13% |
| Aug 7 | $107.06 | $111.06 | $115.21 | +0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $107.06 | $111.06 | $115.21 | +0.16% |
| Week 2 | $105.61 | $111.24 | $117.16 | +0.31% |
| Week 3 | $104.55 | $111.41 | $118.72 | +0.47% |
| Week 4 | $103.69 | $111.59 | $120.08 | +0.63% |
| Week 5 | $102.96 | $111.76 | $121.32 | +0.79% |
| Week 6 | $102.32 | $111.94 | $122.46 | +0.94% |
| Week 7 | $101.74 | $112.11 | $123.54 | +1.10% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico, delivering specialized rehabilitative treatment on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life. The company provides medical, nursing, therapy, and ancillary services to patients and serves them through Medicare, managed care plans and private insurers, state governments, and other patients.
Encompass Health Corporation (EHC) is a healthcare company operating inpatient rehabilitation hospitals. It currently trades at $116.03 per share, with a market cap of $11.51B, and it ranks 824 in market presence. The price sits within a near-term technical context that investors watch for trend confirmation.
A major floor 18.7% below — a decisive break under it would weaken the trend.
The nearest floor, 11.7% below — buyers have tended to step in here.
The nearest ceiling, 4.6% above — a clean break opens room to run.
A major ceiling 14.0% above — clearing it would confirm fresh momentum.
Key EHC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EHC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $113.50 | Sell | $112.79 | Sell |
| MA 10 | $112.64 | Sell | $112.32 | Sell |
| MA 20 | $111.16 | Sell | $110.56 | Buy |
| MA 50 | $105.76 | Buy | $107.46 | Buy |
| MA 100 | $104.42 | Buy | $106.33 | Buy |
| MA 200 | $107.15 | Buy | $106.86 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.73 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -10.65 | Neutral |
| Williams %R (14) | -70.41 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | 1.99 | Buy |
| Bollinger %B (20,2) | 0.47 | Neutral |
| Stochastic %K (14) | 29.59 | Neutral |
| TRIX (15) | 0.34 | Buy |
| Awesome (5,34) | 6.81 | Buy |
| Ultimate (7,14,28) | 49.93 | Neutral |
| Momentum (10) | -1.60 | Sell |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 114.34 | Sell |
| ADX (14) | 23.89 | Buy |
| ATR (14) | 1.42 | Info |
The 30-day technical picture is bullish, with RSI14 at 70, and the price trading above the SMA50 ($105.24) and the SMA200 ($107.35). These indicators point to positive momentum in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $93.83 | $110.89 | $147.66 | 0% | Neutral | |
| $107.66 | $131.31 | $167.34 | +18% | Neutral | |
| $119.67 | $148.73 | $194.76 | +34% | Bullish | |
| $126.00 | $159.04 | $212.73 | +43% | Bullish | |
| $140.92 | $180.28 | $245.52 | +63% | Bullish | |
| $171.13 | $221.61 | $306.62 | +100% | Bullish | |
| $186.61 | $244.40 | $342.99 | +120% | Bullish | |
| $210.17 | $278.17 | $395.45 | +151% | Bullish | |
| $228.20 | $305.05 | $438.87 | +175% | Bullish | |
| $222.21 | $299.85 | $436.21 | +170% | Bullish | |
| $352.46 | $496.11 | $756.42 | +347% | Bullish | |
| $634.87 | $958.48 | $1,566.70 | +764% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $93.83 | $110.89 | $129.15 | +0.00% |
| August 2026 | $95.30 | $111.12 | $132.05 | +0.21% |
| September 2026 | $96.51 | $113.18 | $135.75 | +1.85% |
| October 2026 | $100.55 | $118.46 | $143.14 | +4.67% |
| November 2026 | $102.28 | $120.95 | $147.04 | +2.11% |
| December 2026 | $101.80 | $120.80 | $147.66 | -0.13% |
Click any year to see its month-by-month EHC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect EHC to range from $93.83 to $147.66 through 2026. The $110.89 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The EHC price prediction for 2027 points to an average of $131.31 (low $107.66, high $167.34) — a potential gain of +18% on today's $110.89. Price action looks broadly range-bound.
In 2028, EHC is projected to trade between $119.67 and $194.76, averaging $148.73 — a potential gain of +34% from today's $110.89. That is up +13% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Encompass Health Corporation's 2029 outlook centres on $159.04, within a $126.00 to $212.73 range. That is up +7% on the projected 2028 average. That marks a +43% change versus current levels. Momentum favours further upside here.
By 2030, EHC could reach as high as $245.52, with a base case around $180.28 and support toward $140.92 — roughly +63% from $110.89. Buyers look set to stay in control over this stretch.
Expect EHC to range from $171.13 to $306.62 through 2031. The $221.61 average target implies a +100% move from current prices. That is up +23% on the projected 2030 average. Momentum favours further upside here.
The EHC price prediction for 2032 points to an average of $244.40 (low $186.61, high $342.99) — a potential gain of +120% on today's $110.89. Buyers look set to stay in control over this stretch.
In 2033, EHC is projected to trade between $210.17 and $395.45, averaging $278.17 — a potential gain of +151% from today's $110.89. That is up +14% on the projected 2032 average. Momentum favours further upside here.
Encompass Health Corporation's 2034 outlook centres on $305.05, within a $228.20 to $438.87 range. That is up +10% on the projected 2033 average. That marks a +175% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, EHC could reach as high as $436.21, with a base case around $299.85 and support toward $222.21 — roughly +170% from $110.89. Momentum favours further upside here.
Expect EHC to range from $352.46 to $756.42 through 2040. The $496.11 average target implies a +347% move from current prices. That is up +65% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The EHC price prediction for 2050 points to an average of $958.48 (low $634.87, high $1,566.70) — a potential gain of +764% on today's $110.89. Momentum favours further upside here.
Investing $1,000 in EHC today (≈ 9.017946 EHC) could be worth
$8,643.48
+$7,643.48 (+764%) by 2050 · US Dollar
Based on the average projected EHC price of $958.48 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EHCwould be worth at today's price.
$1,000 invested in EHC on Jul 30, 2025 (≈ 9.094216 EHC) would be worth
$1,008.46
+$8.46 (+0.8%) today · 1.01× · US Dollar
Based on a EHC entry price of $109.96 vs. today's $110.89.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $111.06 | $998.47 | -0.2% |
| 1 month ago | $101.08 | $1,097.05 | +9.7% |
| 3 months ago | $107.48 | $1,031.73 | +3.2% |
| 6 months ago | $94.53 | $1,173.07 | +17.3% |
| 1 year ago | $109.96 | $1,008.46 | +0.8% |
| All time (5.0y) ago | $66.95 | $1,656.23 | +65.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EHC forecast.
Our base-case forecast reaches $220.00 around 2031.
Implied market cap at $220.00: $21.82B
The multi-year forecast lays out a clear path of rising prices and higher ROIs. The 2026 avg price is $116.03 with a neutral sentiment, followed by 2027 avg $137.43 (ROI 18.4) and 2028 avg $155.15 (ROI 33.7). By 2030, the avg is $188.23 with ROI 62.2 and bullish sentiment; by 2040, the avg jumps to $514.33 with ROI 343.3 and bullish sentiment; by 2050, the avg reaches $992.94 with ROI 755.8 and bullish sentiment.
This trajectory also features higher potential max values (e.g., $256.38 in 2030 and $1,623.08 in 2050) that accompany the rising averages.
Tap a question to reveal the answer.
Avg $188.23, Min $147.12, Max $256.38, ROI 62.2, sentiment BULLISH.
Forecasted paths show rising averages over time with ROI progressing from 18.4 in 2027 to 62.2 in 2030 and up to 755.8 by 2050, with sentiment turning bullish from 2028 onward.
Yes—the 2030 max price is $256.38.
Current price $116.03; Market cap $11.51B.
Forecast shows neutral sentiment in 2026-2027 and bullish sentiment from 2028 through 2050.
Encompass Health Corporation Community Discussion
0Share your Encompass Health Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.